What are Envoy Medical's total assets?

Envoy Medical (COCH) holds $29.8M in total assets, up 187.2% year over year.

How much cash does Envoy Medical have?

Envoy Medical holds $25.3M in cash and equivalents.

Can Envoy Medical cover its short-term obligations?

Its current ratio is 2.27 — current assets exceed current liabilities.

Where does Envoy Medical's balance sheet data come from?

Every line is extracted from Envoy Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Envoy Medical COCH Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$3.74M-31.8%	$5.48M+30.0%	$4.22M+2,205%	$183K-83.7%
Accounts receivable, net	$34K-10.5%	$38K-45.7%	$70K+70.7%	$41K—
Inventories	$6.43M+0.7%	$6.39M—	——	$1.44M—
Raw materials	$1.26M-8.9%	$1.39M+19.3%	$1.16M+15.0%	$1.01M—
Work in process	$88K-56.7%	$203K+28.5%	$158K-3.7%	$164K—
Finished goods	$196K+64.7%	$119K+41.7%	$84K-30.6%	$121K—
Prepaid expenses and other current assets	$941K+6.1%	$887K-44.1%	$1.59M+1,131%	$129K-81.9%
Total current assets	$6.28M-29.4%	$8.9M+19.3%	$7.46M+352%	$1.65M+90.9%
Property and equipment, net	$1.04M-18.8%	$1.28M+263%	$351K+6.0%	$331K—
Accumulated depreciation	$5.11M+5.8%	$4.83M+3.7%	$4.66M—	——
Total assets	$8.56M-25.8%	$11.54M+39.5%	$8.27M+224%	$2.56M-99.4%
Accounts payable	$2.92M+76.8%	$1.65M+6.3%	$1.55M+54.9%	$1M+62.1%
Accrued expenses	$334K-36.6%	$527K-18.3%	$645K+6.1%	$608K-70.5%
Accrued interest	$150K-78.6%	$700K—	——	——
Dividends payable	$3.78M+447%	$691K—	——	——
Claims and insurance accruals	$1.27M+2,856%	$43K—	——	——
Total current liabilities	$11.56M+53.4%	$7.54M+3.5%	$7.29M+189%	$2.52M-5.9%
Deferred tax liabilities	-$276K-15.5%	-$239K-1,295%	$20K—	——
Other non-current liabilities	$27K-97.0%	$891K—	——	$127K—
Total liabilities	$20.33M-33.1%	$30.38M+202%	$10.05M-74.1%	$38.75M+0.3%
Common stock	$3K+50.0%	$2K-99.7%	$750K—	——
Additional paid-in capital	$301.36M+13.3%	$266.01M+4.1%	$255.6M+34.6%	$189.9M—
Retained earnings	-$313.4M-10.1%	-$284.73M-10.7%	-$257.26M-13.8%	-$225.99M-516%
Accumulated other comprehensive income (loss)	-$120K+2.4%	-$123K-4.2%	-$118K-2.6%	-$115K—
Total stockholders' equity	-$12.16M+35.5%	-$18.84M-961%	-$1.78M+95.1%	-$36.2M+19.5%
Total liabilities and stockholders' equity	$8.56M-25.8%	$11.54M+39.5%	$8.27M+224%	$2.56M-99.4%
Other accounts receivable (net of allowances of $37 in 2026 and $37 in 2025)	$19K-97.6%	$780K+343%	$176K—	——
Prepaid expenses and other	$358K-26.6%	$488K—	——	——
Other Receivables	$19K-97.6%	$780K+343%	$176K—	——
Deferred Tax Assets and Other Non-Current Assets	$1.69M+34.8%	$1.25M-66.1%	$3.69M—	——
Indefinite-Lived Research and Development Assets	$2.06M-44.6%	$3.72M+89.8%	$1.96M-4.0%	$2.04M—
Net Operating Loss Carryforwards	$1.7M-6.8%	$1.83M-6.7%	$1.96M—	——
Property, plant and equipment at cost	$6.14M+0.6%	$6.11M+21.9%	$5.01M—	——
Tax Credit Carryforward Valuation Allowance	$50.16M-5.0%	$52.78M+5.1%	$50.23M+7,687%	$645K—
Other Commercial Liabilities	$7.64M+106%	$3.71M-19.5%	$4.61M+659%	$608K-70.5%
Accrued Liabilities, Current	$7.64M+106%	$3.71M-19.5%	$4.61M+659%	$608K-70.5%
Other accrued liabilities	$518K-9.6%	$573K-11.2%	$645K—	——
Current portion of accrued product warranty	$287K+1.8%	$282K-9.3%	$311K—	——
Sales taxes payable	$1.93M-14.2%	$2.25M—	——	——
Standard Product Warranty Accrual	$1.89M-7.8%	$2.05M-8.1%	$2.23M-9.8%	$2.48M—
Debt Instrument Convertible Conversion Price	$11.500.0%	$11.500.0%	$11.50—	——
Operating Lease Liability Payments - 2026 (Lessee)	$222K-3.5%	$230K+48.4%	$155K—	——
Operating Lease Liability Payments - 2029 (Lessee)	$186K-6.1%	$198K—	——	——
Unrecognized Tax Benefits	$452K-69.5%	$1.48M+187%	$516K-5.3%	$545K-10.4%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$3K+50.0%	$2K—	——	——
Other Equity	$10M0.0%	$10M0.0%	$10M—	——
Temporary Equity Attributable to Parent	$391K—	——	——	——
Cumulative Cost Basis	$6.14M+0.6%	$6.11M+21.9%	$5.01M—	——
Employee payroll tax withheld on employee stock transactions	$328K+60.8%	$204K—	——	——
Deferred Tax Liabilities, Gross	$808K+86.6%	$433K—	——	——
Deferred Tax Assets, Gross	$50.97M-4.2%	$53.21M+5.0%	$50.67M+14.1%	$44.42M—
Deferred Tax Assets, Net of Valuation Allowance	$808K+86.6%	$433K-1.1%	$438K-99.0%	$44.42M—
Deferred Tax Assets, Operating Loss Carryforwards	$42.3M-2.3%	$43.28M+5.2%	$41.16M+2.1%	$40.3M—
Deferred Tax Assets Startuporganization Costs	$3.22M+2.8%	$3.13M—	——	——
R&D credit carryforward	$31K-6.1%	$33K-93.4%	$500K0.0%	$500K—
Deferred Tax Assets, Valuation Allowance	$50.16M-5.0%	$52.78M+5.1%	$50.23M+7,687%	$645K—
Deferred Tax Liabilities, Other	-$276K-15.5%	-$239K-1,295%	$20K—	——
Estimated Cost Of Warrant Liability Per Unit	$6.000.0%	$6.00—	——	——
Raw materials	$1.26M-8.9%	$1.39M+19.3%	$1.16M+15.0%	$1.01M—
Lease Deposit Liability	$919K—	——	——	——
Other Additional Capital	$10M0.0%	$10M0.0%	$10M—	——
Private Warrant Liability Noncurrent	$5.84M—	——	——	——
Product Liability Contingency Accrual Discount Rate	5.6%+0.4%	5.2%—	——	——
Standard and Extended Product Warranty Accrual	$1.89M-7.8%	$2.05M-8.1%	$2.23M—	——
Long-term portion of accrued product warranty	$1.61M-9.4%	$1.77M-7.9%	$1.92M—	——
Publicly Traded Warrant Liability Noncurrent	$551K-16.8%	$662K+99.4%	$332K—	——
Sale of stock, price per share (in dollars per share)	——	$4.00—	——	——
Unrecognized tax benefits	$452K-69.5%	$1.48M+187%	$516K-5.3%	$545K-10.4%
Warrants And Rights Outstanding	$24K-94.9%	$472K+11,700%	$4K—	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Envoy Medical.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Envoy Medical's total assets?: Envoy Medical (COCH) holds $29.8M in total assets, up 187.2% year over year.
How much cash does Envoy Medical have?: Envoy Medical holds $25.3M in cash and equivalents.
Can Envoy Medical cover its short-term obligations?: Its current ratio is 2.27 — current assets exceed current liabilities.
Where does Envoy Medical's balance sheet data come from?: Every line is extracted from Envoy Medical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.